| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On November 11, 2026, the Board of Directors (the “Board”) of iRhythm Holdings, Inc. (the “Company”) adopted the iRhythm Deferred Compensation Plan (the “Plan”), to be sponsored by the Company and providing for participation by the Compa... |
| 12 Nov 2026 |
8-K: Regulation FD Disclosure; Other Events
SAN FRANCISCO, November 11, 2026 - iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that on November 10, 20... |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, November 5, 2026 -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today reported financial results for th... |
| 05 Oct 2026 |
8-K: Regulation FD Disclosure
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care Combination broadens iRhythm’s cardiac monitoring portfolio, advances its multi-vitals stra... |
| 22 Sep 2026 |
8-K: Regulation FD Disclosure
As previously announced, on August 5, 2026, iRhythm Holdings, Inc., a Delaware corporation (the “Company”), iRhythm Technologies, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Acquirer”), Project Vess... |
| 13 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 11, 2026, Brian Yoor notified iRhythm Holdings, Inc. (the “Company”) of his decision to resign from his position as a member of the Board of Directors of the Company (the “Board”) and as a member and chair of the Audit Committe... |
| 06 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER by and among IRHYTHM TECHNOLOGIES, INC., a Delaware corporation, IRHYTHM HOLDINGS, INC., a Delaware corporation, PROJECT VESSEL MERGER SUB, INC., a Delaware corporation, VITAL CONNECT, INC., a Del... |
| 06 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
SAN FRANCISCO, August 6, 2026 -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three... |
| 15 Jun 2026 |
8-K: Material Cybersecurity Incidents
On June 8, 2026, iRhythm Holdings, Inc. (the “Company”) identified unauthorized activity involving data maintained on certain third-party-hosted business applications. The Company promptly activated its cybersecurity response plan and la... |
| 05 Jun 2026 |
8-K: Regulation FD Disclosure
On June 3, 2026, iRhythm Technologies, Inc. (“iRhythm Tech”), a wholly owned subsidiary of iRhythm Holdings, Inc. (the “Company”), entered into a binding Stipulation and Agreement of Settlement (the “Settlement Agreement”) to fully resol... |
| 28 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
As described in Item 5.07 below, on May 27, 2026, at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of iRhythm Holdings, Inc. (the “Company”), the Company’s stockholders approved the iRhythm Holdings, Inc. 2026 Equity Inc... |
| 30 Apr 2026 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, April 30, 2026 -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three... |
| 01 Apr 2026 |
8-K: Changes in Registrant's Certifying Accountant
March 31, 2026 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by iRhythm Holdings, Inc. (copy attached), which we understand will be filed with the Securities an... |
| 12 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
iRhythm Holdings Appoints Jason Patten to its Board of Directors SAN FRANCISCO, March 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that de... |
| 19 Feb 2026 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, February 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial r... |
| 12 Nov 2025 |
8-K: Regulation FD Disclosure
iRhythm Technologies Proxy Off-Season Shareholder Outreach Fall 2025 |
| 30 Oct 2025 |
8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more
SAN FRANCISCO, October 30, 2025 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the ... |
| 31 Jul 2025 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, July 31, 2025 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the thr... |
| 07 Jul 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
iRhythm Technologies Announces Board Member Retirements and New Director Appointments SAN FRANCISCO, JULY 7, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating tr... |
| 30 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On May 28, 2025, iRhythm Technologies, Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Present at the Annual Meeting in person or by proxy were holders of 30,038,591 shares of the Company’s commo... |
Loading...